Mwanzo068270 • KRX
add
Celltrion Inc
Bei iliyotangulia
₩ 161,300.00
Bei za siku
₩ 159,600.00 - ₩ 163,100.00
Bei za mwaka
₩ 152,666.67 - ₩ 200,952.39
Thamani ya kampuni katika soko
36.21T KRW
Wastani wa hisa zilizouzwa
elfu 452.36
Uwiano wa bei na mapato
79.30
Mgao wa faida
0.44%
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.06T | 178.01% |
Matumizi ya uendeshaji wa biashara | 347.40B | 182.95% |
Mapato halisi | 236.65B | 22,354.46% |
Kiwango cha faida halisi | 22.25 | 7,846.43% |
Mapato kwa kila hisa | elfu 1.15 | 13,270.00% |
EBITDA | 275.17B | 201.50% |
Asilimia ya kodi ya mapato | 14.02% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.14T | 50.90% |
Jumla ya mali | 21.06T | 5.50% |
Jumla ya dhima | 3.48T | 22.75% |
Jumla ya hisa | 17.58T | — |
hisa zilizosalia | 215.26M | — |
Uwiano wa bei na thamani | 1.99 | — |
Faida inayotokana na mali | 2.37% | — |
Faida inayotokana mtaji | 2.52% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (KRW) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 236.65B | 22,354.46% |
Pesa kutokana na shughuli | 305.93B | 104.51% |
Pesa kutokana na uwekezaji | -101.50B | -175.12% |
Pesa kutokana na ufadhili | -228.94B | -214.96% |
Mabadiliko halisi ya pesa taslimu | 23.77B | -88.30% |
Mtiririko huru wa pesa | 61.13B | 103.98% |
Kuhusu
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2002
Tovuti
Wafanyakazi
1,074
